Free Trial

HF Advisory Group LLC Purchases 74,215 Shares of Kenvue Inc. $KVUE

Kenvue logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • HF Advisory Group LLC boosted its Kenvue stake by 47.6%, buying an additional 74,215 shares to hold 230,158 shares worth about $3.97 million, making KVUE 1.3% of its portfolio and its 20th largest holding.
  • Analysts maintain a consensus rating of Hold on Kenvue with a consensus price target of $19.50 after several mixed upgrades and downgrades.
  • Kenvue beat quarterly EPS and revenue estimates and pays a quarterly dividend that annualizes to a 4.8% yield, but the dividend payout ratio is about 107.8%, which may raise sustainability concerns.
  • Interested in Kenvue? Here are five stocks we like better.

HF Advisory Group LLC increased its position in Kenvue Inc. (NYSE:KVUE - Free Report) by 47.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 230,158 shares of the company's stock after purchasing an additional 74,215 shares during the period. Kenvue makes up 1.3% of HF Advisory Group LLC's investment portfolio, making the stock its 20th largest holding. HF Advisory Group LLC's holdings in Kenvue were worth $3,970,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Cornerstone Planning Group LLC lifted its holdings in shares of Kenvue by 705.2% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company's stock worth $25,000 after purchasing an additional 1,361 shares in the last quarter. NBT Bank N A NY lifted its holdings in shares of Kenvue by 180.3% in the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company's stock worth $25,000 after purchasing an additional 1,006 shares in the last quarter. Salomon & Ludwin LLC bought a new position in shares of Kenvue in the 3rd quarter worth $25,000. Golden State Wealth Management LLC lifted its holdings in shares of Kenvue by 150.1% in the 3rd quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company's stock worth $32,000 after purchasing an additional 1,190 shares in the last quarter. Finally, Trust Co. of Vermont lifted its holdings in shares of Kenvue by 50.9% in the 3rd quarter. Trust Co. of Vermont now owns 2,385 shares of the company's stock worth $39,000 after purchasing an additional 804 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on KVUE. Canaccord Genuity Group increased their target price on Kenvue from $17.00 to $18.00 and gave the stock a "hold" rating in a report on Wednesday, February 18th. Argus upgraded Kenvue to a "hold" rating in a report on Friday, March 6th. UBS Group cut their target price on Kenvue from $19.00 to $18.00 and set a "neutral" rating on the stock in a report on Tuesday, April 7th. Citigroup increased their price target on Kenvue from $18.00 to $20.00 and gave the company a "neutral" rating in a research report on Wednesday, February 18th. Finally, Jefferies Financial Group lowered Kenvue from a "buy" rating to a "hold" rating and lowered their price target for the company from $23.00 to $18.00 in a research report on Friday, January 30th. Three research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $19.50.

View Our Latest Report on Kenvue

Kenvue Trading Down 0.4%

NYSE KVUE opened at $17.37 on Friday. The firm has a market capitalization of $33.34 billion, a P/E ratio of 22.55, a PEG ratio of 3.94 and a beta of 0.61. The business has a fifty day simple moving average of $17.96 and a 200 day simple moving average of $17.06. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $25.17. The company has a current ratio of 0.96, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, beating analysts' consensus estimates of $0.22 by $0.05. The business had revenue of $3.78 billion during the quarter, compared to analyst estimates of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.Kenvue's quarterly revenue was up 3.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.26 EPS. On average, analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date of this dividend was Wednesday, February 11th. Kenvue's dividend payout ratio is presently 107.79%.

About Kenvue

(Free Report)

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

See Also

Institutional Ownership by Quarter for Kenvue (NYSE:KVUE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kenvue Right Now?

Before you consider Kenvue, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.

While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2026 Cover

Click the link to see MarketBeat's list of ten stocks that are set to soar in 2026, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines